Interval Debulking Surgery: Clinical Trials

5 trials of Interval Debulking Surgery, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 recruiting, 1 active not recruiting, 1 not yet recruiting, 1 unknown. 3 Phase 2, 2 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 23Recruiting 2, Not yet recruiting 1
Phase 32Active not recruiting 1, Unknown 1

Follow Interval Debulking Surgery: new trials by email Literature Review of Interval Debulking Surgery trials Research Report on Interval Debulking Surgery

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous Ovarian Cancer
Aitua Combination Antibody, Albumin-Bound Paclitaxel /nab-Paclitaxel, Carboplatin (AUC 5) - High-grade Serous Ovarian Cancer (HGSOC), Fallopian Tube Cancers
Phase 2Not yet recruitingCancer Institute and Hospital, Chinese Academy of Medical Sciences822026-03-012026-02-25
Personalized Timing of Interval Debulking Surgery in Advanced Ovarian Cancer
KELIM, Carboplatin plus Paclitaxel, Interval debulking surgery - Ovarian Cancer, Fallopian Tube Cancer
Phase 2RecruitingThe University of Hong Kong1262025-05-222025-07-02
Personalised Timing of Interval Debulking Surgery in Advanced Ovarian Cancer
KELIM, Carboplatin plus Paclitaxel, Interval debulking surgery - Ovarian Cancer, Fallopian Tube Cancer
Phase 2RecruitingThe University of Hong Kong182024-05-282025-07-02
Efficacy of HIPEC as NACT and Postoperative Chemotherapy in the Treatment of Advanced-Stage Epithelial Ovarian Cancer
Hyperthermic Intraperitoneal Chemotherapy, Interval debulking surgery, neoadjuvant chemotherapy - Epithelial Ovarian Cancer, Fallopian Tube Cancer
Phase 3UnknownShu-Zhong Cui2632018-03-012018-01-24
Study of Upfront Surgery Versus Neoadjuvant Chemotherapy in Patients With Advanced Ovarian Cancer (SUNNY)
Upfront cytoreductive surgery, Interval debulking surgery - Epithelial Ovarian Cancer, Fallopian Tube Cancer
Phase 3Active not recruitingShanghai Gynecologic Oncology Group4892016-08-012025-02-10

Conditions studied

Fallopian Tube Neoplasms (5)  ·  Carcinoma, Ovarian Epithelial (2)  ·  Ovarian Neoplasms (2)

Sponsors

The University of Hong Kong (2)  ·  Cancer Institute and Hospital, Chinese Academy of Medical Sciences (1)  ·  Shanghai Gynecologic Oncology Group (1)  ·  Shu-Zhong Cui (1)

Countries

China (3)  ·  Hong Kong (2)  ·  South Korea (1)

Top investigators

Ka Yu Tse, MBBS, MMedSc, PhD, FRCOG (2)  ·  Ning Li, MD (1)  ·  Rongyu Zang, MD,PHD (1)  ·  Shuzhong Cui, M.D (1)  ·  Zhongqiu Lin, M.D (1)

Results publications

PMID 32808504